Since then, new studies have confirmed the roles of some of these signaling molecules, including Substance P and neurotensin as tumor-promoting signals, [50,51,52], somatostatin as a tumor-suppressing signal [53], and galanin as a potential biomarker for CRC in sera and tissue [54,55]. This evidence concerns the gene GAL and colorectal carcinoma.